Literature DB >> 23252569

Expression of IGF-1 receptor in KIT/PDGF receptor-α wild-type gastrointestinal stromal tumors with succinate dehydrogenase complex dysfunction.

Margherita Nannini1, Annalisa Astolfi, Paola Paterini, Milena Urbini, Donatella Santini, Fausto Catena, Valentina Indio, Rita Casadio, Antonio Daniele Pinna, Guido Biasco, Maria A Pantaleo.   

Abstract

KIT/PDGF receptor-α (PDGFRA) wild-type (WT) gastrointestinal stromal tumors (GIST) are characterized by an overexpression of IGF-1 receptor (IGF1R) at the mRNA and protein level. More recently, germline and somatic mutations in succinate dehydrogenase (SDH) subunits A, B and C have been identified in KIT/PDGFRA WT sporadic GIST. Until now, the molecular basis of IGF1R overexpression in KIT/PDGFRA WT GIST has not been explained. In this brief report we investigate the status of the SDH complex at the genomic and protein level in relation to IGF1R expression at the mRNA and protein level in seven KIT/PDGFRA WT sporadic GIST patients. We found that IGF1R was upregulated in all patients harboring SDH mutations or displaying a SDH dysfunction, with respect to KIT/PDGFRA WT GIST without SDH mutations. Western blot analysis confirmed that all patients with an upregulation of IGF1R mRNA had detectable IGF1R protein expression. This report would suggest that IGF1R overexpression in KIT/PDGFRA WT GIST could be driven by the loss-of-function of the SDH mitochondrial complex.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23252569     DOI: 10.2217/fon.12.170

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  12 in total

Review 1.  Succinate dehydrogenase-deficient gastrointestinal stromal tumors.

Authors:  Ya-Mei Wang; Meng-Li Gu; Feng Ji
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

Review 2.  Gastrointestinal stromal tumors (GIST): Facing cell death between autophagy and apoptosis.

Authors:  Gloria Ravegnini; Giulia Sammarini; Margherita Nannini; Maria A Pantaleo; Guido Biasco; Patrizia Hrelia; Sabrina Angelini
Journal:  Autophagy       Date:  2017-01-05       Impact factor: 16.016

3.  Activated tyrosine kinases in gastrointestinal stromal tumor with loss of KIT oncoprotein expression.

Authors:  Yuqing Tu; Rui Zuo; Nan Ni; Grant Eilers; Duolin Wu; Yuting Pei; Zuoming Nie; Yeqing Wu; Yuehong Wu; Wen-Bin Ou
Journal:  Cell Cycle       Date:  2018-12-04       Impact factor: 4.534

4.  Analysis of all subunits, SDHA, SDHB, SDHC, SDHD, of the succinate dehydrogenase complex in KIT/PDGFRA wild-type GIST.

Authors:  Maria A Pantaleo; Annalisa Astolfi; Milena Urbini; Margherita Nannini; Paola Paterini; Valentina Indio; Maristella Saponara; Serena Formica; Claudio Ceccarelli; Rita Casadio; Giulio Rossi; Federica Bertolini; Donatella Santini; Maria G Pirini; Michelangelo Fiorentino; Umberto Basso; Guido Biasco
Journal:  Eur J Hum Genet       Date:  2013-04-24       Impact factor: 4.246

5.  Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations.

Authors:  Maria A Pantaleo; Cristian Lolli; Margherita Nannini; Annalisa Astolfi; Valentina Indio; Maristella Saponara; Milena Urbini; Stefano La Rovere; Antony Gill; David Goldstein; Claudio Ceccarelli; Donatella Santini; Giulio Rossi; Michelangelo Fiorentino; Valerio Di Scioscio; Pietro Fusaroli; Anna Mandrioli; Lidia Gatto; Fausto Catena; Umberto Basso; Giorgio Ercolani; Antonio Daniele Pinna; Guido Biasco
Journal:  Genet Med       Date:  2014-09-04       Impact factor: 8.822

Review 6.  Personalized Medicine in Gastrointestinal Stromal Tumor (GIST): Clinical Implications of the Somatic and Germline DNA Analysis.

Authors:  Gloria Ravegnini; Margherita Nannini; Giulia Sammarini; Annalisa Astolfi; Guido Biasco; Maria A Pantaleo; Patrizia Hrelia; Sabrina Angelini
Journal:  Int J Mol Sci       Date:  2015-07-09       Impact factor: 5.923

7.  Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST).

Authors:  Margherita Nannini; Annalisa Astolfi; Milena Urbini; Valentina Indio; Donatella Santini; Michael C Heinrich; Christopher L Corless; Claudio Ceccarelli; Maristella Saponara; Anna Mandrioli; Cristian Lolli; Giorgio Ercolani; Giovanni Brandi; Guido Biasco; Maria A Pantaleo
Journal:  BMC Cancer       Date:  2014-09-20       Impact factor: 4.430

8.  The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST).

Authors:  Margherita Nannini; Milena Urbini; Annalisa Astolfi; Guido Biasco; Maria A Pantaleo
Journal:  J Transl Med       Date:  2017-05-23       Impact factor: 5.531

9.  Quadruple wild-type (WT) GIST: defining the subset of GIST that lacks abnormalities of KIT, PDGFRA, SDH, or RAS signaling pathways.

Authors:  Maria A Pantaleo; Margherita Nannini; Christopher L Corless; Michael C Heinrich
Journal:  Cancer Med       Date:  2014-08-28       Impact factor: 4.452

10.  Intratumoral KIT mutational heterogeneity and recurrent KIT/ PDGFRA mutations in KIT/PDGFRA wild-type gastrointestinal stromal tumors.

Authors:  Jing Gao; Jian Li; Yanyan Li; Zhongwu Li; Jifang Gong; Jian Wu; Na Liu; Bin Dong; Changsong Qi; Jie Li; Lin Shen
Journal:  Oncotarget       Date:  2016-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.